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Background: The high prevalence of women that do not reach the recommended level of physical activity is
worrisome. A sedentary lifestyle has negative consequences on health status and increases health care costs. The
main objective of this project is to assess the cost-effectiveness of a primary care-based exercise intervention in
perimenopausal women.
Methods/Design: The present study is a Randomized Controlled Trial.
A total of 150 eligible women will be recruited and randomly assigned to either a 16-week exercise intervention
(3 sessions/week), or to usual care (control) group.
The primary outcome measure is the incremental cost-effectiveness ratio. The secondary outcome measures are:
i) socio-demographic and clinical information; ii) body composition; iii) dietary patterns; iv) glycaemic and lipid
profile; v) physical fitness; vi) physical activity and sedentary behaviour; vii) sleep quality; viii) quality of life, mental
health and positive health; ix) menopause symptoms. All outcomes will be assessed at baseline and post intervention.
The data will be analysed on an intention-to-treat basis and per protocol. In addition, we will conduct a cost effectiveness
analysis from a health system perspective.
Discussion: The intervention designed is feasible and if it proves to be clinically and cost effective, it can be easily
transferred to other similar contexts. Consequently, the findings of this project might help the Health Systems to identify
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Trial registration: ClinicalTrials.gov Identifier: NCT02358109. Date of registration: 05/02/2015
Keywords: Cost-effectiveness, Health status, Quality of life, Physical activity, Physical fitness, Primary care* Correspondence: virginiaparicio@ugr.es
7Department of Physiology, Faculty of Pharmacy, Faculty of Sport Sciences,
and Institute of Nutrition and Food Technology, University of Granada,
Granada, Spain
8Department of Public and Occupational Health, EMGO+ Institute for Health
and Care Research, VU University Medical Centre, Amsterdam, The
Netherlands
Full list of author information is available at the end of the article
© 2015 Carbonell-Baeza et al. This is an Open
License (http://creativecommons.org/licenses/
medium, provided the original work is proper
creativecommons.org/publicdomain/zero/1.0/Access article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Carbonell-Baeza et al. BMC Public Health  (2015) 15:555 Page 2 of 11Background
Physical inactivity is a pandemic and a leading risk factor
for mortality [1]. Worldwide, 31.1 % of adults are physic-
ally inactive [2]. Inactivity rises with age, is higher in
women than in men, and is increased in high-income
countries [2]. In Spain, 50.2 % of adults are physically in-
active (47.4 and 53.1 % in men and women, respectively)
[2]. The elevated percentage of women who do not
reach recommended level of physical activity is worri-
some. A recent study in Spain [3] found that women
aged from 41 to 50 years emerged as the groups with a
greater likelihood of being sedentary in their leisure time.
This physical inactivity-derived problem can be especially
relevant during the perimenopausal period. Beyond the
negative effects of physical inactivity [1], menopause in-
creases cardiometabolic risk factors due to the significant
decline in the estrogen levels [4, 5]. Moreover, menopause-
related testosterone predominance appears to be implicated
as a key hormonal change associated with the incidence of
metabolic syndrome, independent of aging and other stand-
ard cardiovascular disease (CVD) risk factors [6]. Regular
physical activity is associated with decreased risk of CVD
and type 2 diabetes in middle aged women, independently
of their menopause status [7]. Similarly, some studies ob-
served that postmenopausal women with high physical
activity levels had a more favourable CVD risk profile than
their physically inactive peers [8, 9]. Additionally, higher
physical activity is directly associated with better health-
related quality of life [10, 11]. Indeed, exercise interventions
can improve sleep quality [12] and depression [13] in mid-
dle adult women. However, the role of physical activity in
clinical practice remains undervalued despite increasing
evidence supporting its protective effects and the economic
burden associated with a sedentary lifestyle [1].
National Health expenditures in Spain have increased
from 7.2 % of the gross domestic product (GDP) in 2001
to 9.3 % in 2011 [14]. The pharmacological treatment
costs are specially increasing in European countries [14].
In Spain, pharmacological costs represent 1.6 % of the
GDP, and 17.4 % of the National Health Expenditures
[14]. Previous studies have shown that regular physical
activity reduces health care requirements and thereby
leads to significant savings in health-care costs [15, 16].
In 2005, the Spanish Ministry for Health and Con-
sumption designed the Strategy for Nutrition, Physical
Activity and Prevention of Obesity (NAOS) with the aim
of promoting a healthy lifestyle among the general popu-
lation. Additionally, in May 2009 the Spanish National
Sports Council launched the Integral Plan on Physical
Activity and Sport (A + D Plan). This plan included a
specific program focused on women, with the objective
of increasing their physical activity levels. In this context,
we designed the Fitness League Against MENopause
COst (FLAMENCO) project, a randomized controlledtrial to investigate the cost-effectiveness of an exercise
intervention in primary care settings in middle aged
women.
The primary aim of the FLAMENCO project is to as-
sess the cost-effectiveness of a primary care-based exer-
cise intervention program (16 weeks) in perimenopausal
women. In addition, we will address the following spe-
cific objectives: i) to determine the associations between
physical activity, sedentary behaviour and physical fitness
with CVD biomarkers, body composition, dietary pat-
terns, glycaemic and lipid profile, sleep quality, quality of
life, mental health, positive health and menopause symp-
toms; and ii) to study the associations between the above
mentioned variables with pharmacological and health
service costs.
The purpose of this methodological article is to de-
scribe the study design, procedures and methods that
will be used in the “FLAMENCO project”.
Methods/Design
The present study is a Randomized Controlled Trial
(RCT) (registration number: NCT02358109). The study
protocol has been reviewed and approved by the Ethics
Committee for Research Involving Human Subjects at
the University of Granada. The participants will have to
provide a written informed consent before taking part in
the study, which will be conducted in accordance with
the CONSORT (Consolidated Standards of Reporting
Trials) statement.
Participants and recruitment process
Women will be recruited through primary care centres
from Granada (Southern Spain). Medical staff will re-
cruit possible candidates for participation during consul-
tations at the primary care centres. Furthermore, press
releases will be published in local newspaper and on so-
cial media (radio, internet, etc.). Moreover, information
leaflets will be distributed in primary care centres and
informative meetings with potential participants will be
carried out.
A screening of all candidates will be performed. The
inclusion and exclusion criteria are shown in Table 1.
The organizational and participants flow is presented in
Fig. 1.
Sample size
The number of participants to be included in the study
was calculated on the basis of the change in quality of
life as assessed with the EuroQol 5D (EQ-5D-5 L). To
the best of our knowledge, there is no available data re-
garding group differences in changes in quality of life
following any type of intervention in middle aged
women. Therefore, we assumed a difference of 0.07 units
as clinically meaningful based on previous observations
Table 1 Inclusion and exclusion criteria in the FLAMENCO project
Inclusion criteria
- Age: 45–60 years old.
- Not to have severe somatic or psychiatric disorders, or diseases
that prevent physical exercise (Answer “no” to all questions on
the PAR-Q).
- Not to be engaged in regular physical activity >20 min on >3 days/
week in the last three months.
- To be able to ambulate without assistance.
- To be able to communicate.
- Informed consent: To be capable and willing to provide informed
consent.
Exclusion criteria
- Acute or terminal illness.
- Myocardial infarction in the past 3 months.
- Unstable cardiovascular disease or other medical condition.
- Upper or lower extremity fracture in the past 3 months.
- Unwillingness to either complete the study requirements or to be
randomised into control or intervention group.
- Presence of neuromuscular disease or drugs affecting neuromuscular
function.
PAR-Q: Physical Activity Readiness Questionnaire
Fig. 1 The organizational and participants flow
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total of 124 participants (62 per group) is needed to de-
tect a mean group difference of 0.07 and a standard de-
viation of 0.12 in the total EQ-5D score with a power of
90 % and α of 0.05. However, we will attempt to exceed
this sample size to allow for withdrawals. Assuming a
maximum lost-to-follow up of 20 %, a minimum of 75
participants per group will be recruited (n = 150).
Randomization and blinding
After baseline assessments, all participants will be random-
ized to either exercise intervention or control (non-exer-
cise) group. A computer generated simple randomization
sequence will be created before participants will be enrolled,
to allocate participants to either the exercise intervention or
control group (1:1). The randomization sequence will be
prepared by a member of the research team with no clinical
involvement in the trial. The allocation will be concealed in
a password protected computer file. Whereas the partici-
pants will be aware of their group allocation, outcome as-
sessors and data analysts will be blinded to the allocation.
Interventions
The participants randomly assigned to the usual care
(control) group will receive general advices from primary
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physical activity. The researchers will give 4 conferences
(1 per month) explaining the benefits of exercise for
longevity, prevention and treatment of diseases, the ben-
efits of the Mediterranean diet, nutritional education,
ergonomic advises, exercise to perform at home (e.g.
stretching, strength training) and strategies to increase
their daily physical activity levels.
The exercise intervention will be performed in four
groups so that each group will comprise 15–20 par-
ticipants. The groups will train 3 days/week (60 min per
session) for a 16-week period at the primary care centre
of Granada. The exercise intervention will meet the
training standards of the American College of Sports
Medicine [17] for adults. The exercise sessions will be
designed, carefully supervised, guided and instructed by
qualified exercise professionals.
Each exercise session will include a 10 min warm-up
period with walks and mobility exercises, followed by
40 min of a main part which will vary across week days
(i.e. 3 different models of session). Sessions will finish
with a 10 min cool-down period of stretching and relax-
ation exercises. The three model sessions will be: (i) First
session of the week will involve circuit training including
resistance exercises in a stepped progression during the
program. Resistance circuit training will include 2–3 set
of 6–10 exercises. The participants will perform 10–20
repetitions of multi-joint exercises and/or single joint
exercises targeting major muscle groups such as biceps
curls, triceps extensions, arm side lifts, shoulder eleva-
tions, chest press, lateral leg elevations, stands up from
seated position, lunge, sideways lunge and step-up/step-
down, squads, lower back extensions, abdominal
crunch/curl-up and calf raises among others. Partici-
pants will carry out bodyweight exercises at the begin-
ning of the program and, if it is necessary, free weights
(0.5–3 kg barbells) and resistance bands will be used to
reach the optimal intensity. The load will be gradually
increased and each participant will individualize her ef-
fort to reach the intensity designed for each session; (ii)
Second session of the week will include balance-
oriented activities (position changes, monopodal and
bipodal stances, backwards walks, …) and dancing (aer-
obic exercises); (iii) Third session of the week will com-
bine aerobic, resistance strength and coordination
exercises.
Heart rate will be measured with heart rate monitors
(Polar Electro OY, Finland) to control the intensity of
the sessions. One third of the participants in the inter-
vention group will wear heart rate monitors in 1/3 of the
sessions, both randomly selected. We will monitor the
ratings of perceived exertion (RPE) using the Borg 6-20
RPE scale [18] during all the sessions. Intensity
(expressed as RPE) will be expected to range from 12 to16. The exercise volume and intensity programmed is
shown in Table 2.
To maximize adherence, several strategies will be im-
plemented including music in all sessions, individualized
attention during the intervention sessions, and telephone
calls following non-attendance. The researchers will con-
trol and register the presence of adverse event during
and between classes.
Primary and secondary outcomes
Primary outcomes
The Incremental Cost Effectiveness Ratio (ICER) [19].
For each group (intervention and control) an average of
cost and health effects will be calculated. The measure-
ment of health effects is defined as the Quality Adjusted
Life Years (QALYs). The QALYs are calculated multiply-
ing the years of life by the participants’ quality of life.
The participants’ quality of life will be assessed by the
EQ-5D-5 L questionnaire. The ICER will be calculated
dividing the difference between the average costs of both
groups by the difference in mean QALYs gained in both
groups [19].
ICER ¼ CostIntervention −CostControl
QALYIntervention −QALYControl
Secondary outcomes
Socio-demographic and clinical information
Demographic and other health information will be col-
lected using a questionnaire. This anamnesis will include
questions regarding smoking and alcohol habits, history
of illness (as osteoporosis, CVD, hypertension, diabetes),
menopause status, indicators of socio-economic status
(such as personal and household income, education
level…), marital status, and number of children. The
pharmacology register as well as the number and reason
of medical visits will be consulted by the primary care
medical staff in collaboration with members of the re-
search team through the medical database.
Systolic and diastolic blood pressure, as well as resting
heart rate, will be measured after 5 min of rest, on 2 separ-
ate occasions (with 2 min between trials), with the person
seated (Omron Health Care Europe B.V. Hoolddorp). The
lowest value of the two trials will be selected for the
analysis.
Body composition
Lean, fat and bone mass of the whole body will be mea-
sured using a dual-energy x-ray absorptiometry (DXA)
device (Hologic Discovery QDR, Nasdaq: HOLX).
Height (cm) will be measured using a stadiometer (Seca
22, Hamburg, Germany). Waist circumference (cm) will
be assessed at the middle point between the ribs and the
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thropometric tape, Holtain Ltd).
Dietary patterns
The Mediterranean Diet Score [20] is an index created
to evaluate the degree of adherence to the traditional
Mediterranean dietary pattern. It consists of 11 items
(non-refined cereals, potatoes, fruits, vegetables, le-
gumes, fish, olive oil, red meat and derivate, poultry, full
fat dairy products and alcohol), which scores ranging
from 0–5 based on frequency of consumption. Thus, the
total score ranges from 0–55, with higher scores indicat-
ing greater adhesion to the Mediterranean dietary pattern.
The Food Frequency questionnaire [21] consists on a
list of 78 foods on which participants will be asked to in-
dicate the frequency of consumption (never or number
of times per day, per week, per month or per year).
Glycaemic and lipid profile
Venous blood samples will be collected in two vacuum
tubes in standardized fasting conditions at 8–9 a.m. in
the primary care centre and transported to the labora-
tory for subsequent analysis. One of these vacuums will
contain EDTA/K3 to determine blood cells count, blood
haemoglobin concentration and haematocrit. Plasma
total cholesterol, high-density lipoprotein cholesterol,
low-density lipoprotein cholesterol, triglycerides, glu-
cose, insulin, albumin, glycosylated haemoglobin and
thyroid-stimulating hormone levels will be assessed with
standard methods using an autoanalyzer (Hitachi-Roche
p800, F. Hoffmann-La Roche Ltd. Switzerland).
Physical fitness
Participants’ physical fitness status will be assessed by
means of the following tests:
Cardiorespiratory fitness The modified Bruce protocol
[22, 23] will be performed to estimate maximal oxygen
uptake (VO2max), and will be used as measure of cardio-
respiratory fitness. The test will consist of 5 increasing
workload stages of 3 min each (stage 1: 2.7 km/h and
10 % inclination; stage 2: 4 km/h and 12 % inclination;
stage 3: 5.5 km/h and 14 % inclination; stage 4: 6.8 km/h
and 16 % inclination; stage 5: 8 km/h and 18 % inclin-
ation). The test will conclude when the 85 % of the indi-
vidual’s heart rate reserve (HRR) is accomplished.
VO2max will be estimated with the formula by Bruce
et al. [23]: VO2max = 6.70 – 2.82*2 + 0.056*duration of
the test (s).
We will additionally perform the 6-min walk test,
which measures the maximum distance (in meters) each
participant can walk in 6 min along a 45.7 m rectangular
course [24].Lower-body muscular strength The 30-s chair stand
test involves counting the number of times within 30 s
that the participant can rise to a full stand from a seated
position with back straight and feet flat on the floor,
without pushing off with the arms. The participants will
perform one trial after familiarization [24].
Upper-body muscular strength The arm curl test in-
volves determining the number of times a hand weight
(2.3 kg for women) can be curled through a full range of
motion in 30 s seconds [24]. Additionally, handgrip
strength test will be measured using a digital dynamom-
eter (TKK 5101 Grip-D; Takey, Tokyo, Japan) as de-
scribed elsewhere [25]. The participants will perform
(alternately with both hands) these tests twice. The best
value of 2 trials for each hand will be chosen and the
average of both hands will be used in the analyses.
Lower-body flexibility The sit and reach test required
the use of the sit-and-reach standardized box with a
slide ruler attached to the top [26]. The participant will
be required to sit with knees straight and legs together,
and feet placed against the box. The participant slowly
will reach forward as far as possible [26]. The final pos-
ition that the participant reach in centimetres will be
the test score. The best score of two attempts will be re-
corded. Additionally, the back saver sit and reach test
will be carried out in the same sit-and-reach standard
box described above. The participant will be required to
sit with the untested leg bent at the knee and the tested
leg with the knee straight and feet place against the box.
The scoring is the same as the sit and reach test but
only one leg is evaluated at a time. The best score of
two attempts for each leg in centimetres will be re-
corded and the average of both legs will be used in the
analyses.
Upper-body flexibility The back scratch test, a measure
of overall shoulder range of motion, involves measuring
the distance between (or overlap of ) the middle fingers
behind the back with a ruler [24]. The best score of two
attempts for each arm in centimetres will be recorded
and the average of both arms will be used in the
analyses.
Motor agility/dynamic balance The timed up and go
test [27] will be performed to assess the dynamic bal-
ance. The participant will be seated in a chair with arms
and trunk supported. The participant will be instructed
to stand up on the word “go” and walk 3 meters in a
straight line, turned 180°, walk back to the chair and sit
down again in the chair. One familiarization trial will be
undertaken. After 1-min rest, the test will be performed
twice separated by 1-min. The time from the start until
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will be measured and the best of the 2 attempts will be
used.
Self-perceived physical fitness The International Fitness
Scale [28] consists of five Likert scale questions asking
how participants perceive their overall fitness, cardio-
respiratory fitness, muscular strength, speed-agility and
flexibility (“very poor”, “poor”, “average”, “good” and
“very good”) in comparison with their friends.
Physical activity and sedentary behaviour
Accelerometry will be used to objectively assess physical
activity and sedentary time. Women will be asked to
wear a tri-axial accelerometer (GT3X+, Pensacola, Flor-
ida, USA) for 9 consecutive days, starting the same day
they receive the monitor (e.g. participants who receive
the accelerometer on Monday, will carry the device until
Tuesday of the next week). The first and last day will be
excluded from the analyses, accounting for a total of
7 days of registering. Participants will be instructed to
wear the accelerometer during the whole day (24 h) on
their lower back attached by an elastic belt. To prevent
any damage to the devices, these will be taken off during
water-based activities such as bathing or swimming.
Time engaged in light, moderate, and moderate-
vigorous intensity physical activity and sedentary time
will be calculated.
The Sedentary Behaviour Questionnaire [29, 30] as-
sesses the amount of time spent doing 11 behaviours.
The 11 items will be completed separately for weekday
and weekend. Response options are none, 15 min or less,
30 min, 1 h, 2 h, 3 h, 4 h, 5 h, or 6 h or more. The time
spent on each behaviour will be converted into hours
(e.g., a response of 15 min will be recorded as 0.25 h).
For the total scores of sedentary behaviour, hours per
day for each item will be summed separately for weekday
and weekend. To obtain weekly estimates, weekday
hours will be multiplied by 5 and weekend hours will be
multiplied by 2 and these will be summed for total
hours/week.
The short version of the ALPHA Environmental ques-
tionnaire [31] will be used to assess environmental per-
ceptions about physical activity. The questionnaire will
provide information about types of residences in the
neighbourhood, distances to local facilities, walking or
cycle infrastructure in the neighbourhood, cycling and
walking network, neighbourhood safety, home and
work/study environment mode of active travel.
Sleep quality
The Pittsburgh Sleep Quality Index [32] will be used to
assess sleep quality and disturbances over a l-month
time interval. Nineteen individual items generate seven“component” scores: subjective sleep quality, sleep la-
tency, sleep duration, habitual sleep efficiency, sleep dis-
turbances, use of sleeping medication, and daytime
dysfunction. Each component yields a score ranging
from 0 to 3, with 3 indicating the greatest dysfunction.
The seven component scores are summed to provide a
global sleep quality score (range 0 to 21) with higher
scores indicating poorer sleep quality.Quality of life, mental health and positive health
We will determine participants’ quality of life with the
Short-Form Health Survey 36 (SF-36) [33]. The SF-36 is
a generic instrument for assessing health-related quality
of life. It contains 36 items grouped into 8 dimensions:
physical functioning, physical role, body pain, general
health, vitality, social functioning, emotional role, and
mental health. The scores range from 0 to 100 in every
dimension, where higher scores indicate better health.
The EQ-5D-5 L consists of two parts. The first will be
used to assess 5 dimensions of health related quality of
life: mobility, self-care, usual activities, pain/discomfort
and anxiety/depression, each of which is defined through
five severity levels [34, 35]. The instrument therefore de-
fines 3125 different health states from all the possible
combinations of dimensions and levels of severity. EQ-
5D-5 L health states may be converted into a single
index value [34, 35]. This index ranges from 1 (best
health status) to 0 (death). The second part consists of a
20-cm, vertical visual analogue scale (VAS), in the form
of a thermometer, with endpoints of worst and best im-
aginable health status (scored 0 and 100, respectively)
[34, 35]. This questionnaire will be administered at 3 dif-
ferent time points: at the beginning of the study, at
8 weeks and at 16 weeks, moreover it will be used to
perform the cost-utility analysis.
The Rosenberg Self-Esteem Scale [36] is a 10-item scale
to analyse the global self-esteem [37]. Each item is rated
on a 4-point Likert scale, ranging from 1 = “strongly dis-
agree” to 4 = “strongly agree”. The score ranges from 10
to 40, and higher scores reflect greater self-esteem.
The brief COPE [38, 39] is a 28-item scale that as-
sesses coping strategies. Participants will be asked to
rate how often they use specific coping strategies on a
4-point Likert scale, from 0 = “I haven’t been doing this
at all” to 3 = “I’ve been doing this a lot”. The 28 items
are paired together describing 14 different coping strat-
egies: active coping, planning, positive reframing, ac-
ceptance, humour, religion, use of emotional support,
use of instrumental support, self-distraction, denial,
venting, substance use, behavioural disengagement and
self-blame. Score for each subscale ranges from 0 to 6,
and higher score indicates more frequency of the par-
ticular coping strategy.
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scale to analyze the global self-efficacy. Each item is
rated on a 4-point Likert scale, ranging from 1 = “not all
true“ to 4 = “exactly true”. The score ranges from 10 to 40
where higher scores reflect greater general self-efficacy.
The Beck Depression Inventory-II [42, 43] will be used
to assess depression severity. It contains 21 items meas-
uring depressive symptoms such as sadness, pessimism,
suicidal thoughts or wishes, tiredness or fatigue, loss of
energy, and loss of pleasure, among others. Each item is
scored on a scale ranging from 0 to 3. The global score
ranges from 0 to 63 with higher score indicating greater
degree of depression. A score of ≤13, 14–19, 20–28,
and ≥29 represents minimal, mild, moderate, and se-
vere depressive symptoms, respectively
The State Trait Anxiety Inventory [44] consists of 2
scales for measuring state anxiety and trait anxiety. Each
scale comprises 20 items with scores ranging from 1 to 4.
The total score of each scale ranges from 20 to 80 and
higher values indicate higher levels of anxiety.
Positive health will be assessed by means of the follow-
ing questionnaires:
1) The Trait Meta-Mood Scale [45] is comprised of 3
subscales to assess emotional attention, emotional
clarity and emotional repair. Each subscale
comprises 8 items. Participants rate their responses
using a 5-point Likert scale, with
1 = “strongly disagree” to 5 = “strongly agree”. The
subscales score range from 8 to 40 and higher scores
reflect greater emotional attention, clarity, and
repair.
2) The Positive and Negative Affect Schedule [46, 47] is
a 20-item questionnaire designed to measure positive
and negative affect. The questionnaire includes 10
positive and 10 negative emotional states that should
be answered on a 5-point Likert scale, from 1 = “very
slightly or not at all” to 5 = “extremely”. The score
ranges from 10 to 50 for both subscales (positive
affect and negative affect), and higher scores reflect
greater affective well-being.
3) The Satisfaction with Life Scale [48, 49] assesses the
perceived global life satisfaction. It consists of 5
items with a 5-point Likert scale from 1 = “strongly
disagree” to 5 = “strongly agree”. The score ranges
from 5 to 25, and higher scores reflect greater life
satisfaction.
4) The Life Orientation Test Revised [50, 51] is a
10-item scale that assesses participants’ expectations
about their future and their general sense of
optimism. Six items (three reverse-scored) are used
to obtain the total optimism score. Each item is
rated on a 5-point Likert scale ranging from 0
(“strongly disagree”) to 4 (“strongly agree”). The totalscore ranges from 0 to 24, with higher scores
indicating higher levels of optimism. The remaining
4 items are filler questions.
5) The Subjective Happiness Scale [52, 53] is a 4-item
scale that assesses the global subjective happiness.
Each item is rated on a 7-point Likert scale (e.g., “In
general, I consider myself”, from 1 = “Not a very
happy person” to 7 = “A very happy person”). The
total score is the mean of all the four items, ranging
from 1 to 7, and higher score indicates greater sub-
jective happiness.
6) The 10-item Connor-Davidson Resilience Scale [54, 55]
assesses resilience to stress, which is a construct
refering to a dynamic process of positive adaptation to
adverse changes in life circumstances [56, 57]. Each
item ranges from 0 = “not true at all” to 4 = “true
nearly all the time”. The total score range from 0 to 40,
and higher scores indicate greater resilience.Menopause symptoms
The Blatt-Kupperman menopausal index [58] consists of
11 items including sweating/hot flushes, palpitation, ver-
tigo, headache, paraesthesia, formication, arthralgia, and
myalgia (categorized as somatic symptoms), and fatigue,
nervousness, and melancholia categorized as psycho-
logical symptoms. A scale ranging from 0 to 3 points is
used to describe the severity of the complaints. The total
score ranges from 0 to 63, calculated as the sum of all
items by the weighting factor. Scores ranging from 0–6,
7–15, 16–30, and 30 are used to rate the degree of sever-
ity as none, mild, moderate, and severe, respectively.
The Cervantes scale [59] is a health-related quality of
life questionnaire specific for the menopause. The scale
has 31 items and covers 4 domains: menopause and
health (15 items), psychological domain (9 items), sexu-
ality (4 items), and couple relationship (3 items). Each
item score ranging from 0 to 5. The global score range
from 0 to 155 (from better to worse quality of life).Measurements procedures
The women will be cited three days to complete all the
measurement protocol. The first day, participants will
attend the primary care centre and complete the follow-
ing assessments in the same order as presented here:
socio-demographic and clinical information, blood pres-
sure and resting heart rate, body composition and phys-
ical fitness. The participant will then receive the
accelerometer and all the questionnaires to be com-
pleted at home and will be cited eight days later to
return them. Additionally, the primary care centre will
cite participants another day for the biochemical
analysis.
Carbonell-Baeza et al. BMC Public Health  (2015) 15:555 Page 9 of 11Statistical analysis
Baseline characteristics of the study participants will be
presented as mean (standard deviation) for continuous
variables and proportions for categorical variables.
Statistical analysis will be performed on the intention
to treat population, thus including all randomized partic-
ipants (in the groups to which they were randomly
assigned) in the analysis. Missing data will be replaced
using multiple imputations. The effects of the interven-
tion on the primary and secondary outcomes will be
assessed with repeated measures analysis of covariance
adjusted for age and baseline values. The effect size
(95 % confidence interval) and statistical significance will
be reported for each study outcome with regards to the
main group (between-subjects) time (within-subjects)
and their interaction (group × time) effects. The statistical
significance will be set at the conventional level of p<0.05.
To account for potential estimations biases or inefficiency,
sensitivity analyses will be undertaken using baseline ob-
servation carried forward imputation, and also the avail-
able case population (participants who actually received
the treatment; i.e. no imputations).
Ancillary analyses. "Per-protocol" analyses will also be
performed on participants with overall ≥75 % treatment
compliance.
Cost-effectiveness analysis
A cost-utility analysis with a health system perspective
will be conducted in line with the methodological rec-
ommendations suggested by Lopez-Bastida et al. [60],
and the guidelines defined in the economic evaluation
literature [19, 61].
The study will be conducted considering the costs and
the health effects of the intervention. Only direct costs
of the program will be identified and valued. As direct
costs for both groups, the drugs consumption, primary
care visits, and hospital admissions will be considered.
In the intervention group, the time dedicated by sport
professionals of the exercise program will also be consid-
ered. Their total remuneration will be calculated based
on the collective agreement for these professionals. First,
for each group (intervention and control) an average of
cost and effectiveness (the mean QALYs gained) will be
calculated. Secondly, the ICER [19] will be calculated.
To analyse the uncertainty in model parameters and ver-
ify the robustness of the ICER, various deterministic and
probabilistic sensitivity analyses will be held [62]. The
probabilistic analysis will be carried out through boot-
strapping non parametric methods with 1000 replica-
tions. The resulting 1000 ICER replications will be
plotted on the cost-effectiveness plane and will be used
to construct an acceptability curve [63]. The cost-
effectiveness plane is a graphical way of presenting cost-
effectiveness results, with the difference in costs on thevertical axis and the difference in health benefits on the
horizontal axis. Since incremental costs and health bene-
fits can both be either positive or negative, there are four
possible combinations, which will be reflected in the
four quadrants of the cost-effectiveness plane:
– Upper-left quadrant: intervention less effective and
more costly than comparator.
– Lower-left quadrant: intervention less effective and
less costly than comparator.
– Upper-right quadrant: intervention more effective
and more costly than comparator.
– Lower-right quadrant: intervention more effective
and less costly than comparator.
The acceptability curve represents the proportion of
simulations in which the intervention was considered
cost-effective over a range of values of the threshold
cost- per-QALY [64]. All analyses will be conducted in
Stata v.13 (Stata Corp, College Station, TX, USA).
Discussion
This paper describes the protocol for a RCT that aims to
determine the clinical and cost-effectiveness of a primary
care-based exercise intervention in perimenopausa women.
Physical activity during the menopause transition and post
menopause period has been reported to improve mental
health, prevent weight gain, increase bone mineral density
and muscle mass and reduce the risks of other diseases (e.g.
cancer, diabetes, heart disease) [5, 65]. Additionally, increas-
ing evidence suggests that exercise is a safe and useful
strategy for alleviating menopause symptoms [65], with no
serious reported side-effects [65]. For all those reasons, pol-
icy makers should consider encouraging general practi-
tioners to prescribe exercise programs in primary care
settings in collaboration with exercise specialists [66]. In
Spain, the 2012 national health survey [67] revealed that
82 % of the population visited primary health care centres,
making this an ideal setting for undertaking exercise inter-
vention programs [68]. Most interventions to increase
physical activity in primary care have been cost-effective
[68]. A review showed the effectiveness of at least
12 months of primary care-based interventions to promote
physical activity [69]. However, most of the interventions
involved advice or counselling given face to face, or by
phone (or both), and few trials have investigated supervised
exercise interventions [69]. Further exercise interventions
are needed, with objective outcome measures [69]. This
project will be a primary care-based RCT and its results
may potentially be generalizable to similar primary care set-
tings. The designed intervention is also feasible and non-
expensive. If the present RCT proves to be effective, it can
be easily transferred to other similar contexts. Additionally,
we will analyse the association of physical activity, sedentary
Carbonell-Baeza et al. BMC Public Health  (2015) 15:555 Page 10 of 11behaviour and physical fitness with the other variables reg-
istered and with pharmacological and health service costs.
Consequently, the findings of the FLAMENCO Project will
help the health care system to identify preventive strategies
for primary prevention and health promotion as well as
strategies to reduce health care requirements and cost.
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